H. Morris

The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist.

J. Buccafusco, M. Abou-Gharbia, S. Rosenzweig-Lipson, 2000, The Journal of pharmacology and experimental therapeutics.

WAY‐131256 is an orally active, efficacious, and in vivo functionally selective M1 agonist

M. Abou-Gharbia, A. Sabb, D. Ho, 1997 .

Synthesis and SAR of adatanserin: novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT(1A) and 5-HT(2) activity as potential anxiolytic and antidepressant agents.

G. McGaughey, K. Marquis, U. Patel, 1999, Journal of medicinal chemistry.

Arecoline via Miniosmotic Pump Improves AF64A-Impaired Radial Maze Performance in Rats: A Possible Model of Alzheimer's Disease

C. Boast, A. Bartolomeo, H. Morris, 1997, Neurobiology of Learning and Memory.

5HT Antagonists Attenuate MK801-Impaired Radial Arm Maze Performance in Rats

C. Boast, J. Moyer, A. Bartolomeo, 1999, Neurobiology of Learning and Memory.

Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.

D. Howlett, S. Nahorski, H. Morris, 1979, Molecular pharmacology.

CHAPTER 45 - Preliminary Evaluation of the Glycine Site Antagonists [ 11 C]L 703,717 and [ 3 H]MDL 105,519 as Putative PET Ligands for Central NMDA Receptors: In Vivo Studies in Rats

S. Luthra, S. Osman, S. Hume, 1998 .

CHAPTER 40 – Use of Information Technology in the Search for New PET Tracers

H. Morris, Tim Jones, A. J. Abrunhosa, 1998 .

Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639

A. Sabb, C. Boast, M. Abelson, 1991, Pharmacology Biochemistry and Behavior.